Evidence map›Paper›PMID 41664802›Full record

Article... Clinical Natural Language Processing Workshop : proceedings of the workshop2024

UMass-BioNLP at MEDIQA-M3G 2024: DermPrompt - A Systematic Exploration of Prompt Engineering with GPT-4V for Dermatological Diagnosis.

Parth Vashisht, Abhilasha Lodha, Mukta Maddipatla, Zonghai Yao, Avijit Mitra, Zhichao Yang, Junda Wang, Sunjae Kwon, Hong Yu

Abstract read
In one paragraph

Article in ... Clinical Natural Language Processing Workshop : proceedings of the workshop, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Parth VashishtCICS, University of Massachusetts, Amherst, MA, USA.
Abhilasha LodhaCICS, University of Massachusetts, Amherst, MA, USA.
Mukta MaddipatlaCICS, University of Massachusetts, Amherst, MA, USA.
Zonghai YaoCICS, University of Massachusetts, Amherst, MA, USA.
Avijit MitraCICS, University of Massachusetts, Amherst, MA, USA.
Zhichao YangCICS, University of Massachusetts, Amherst, MA, USA.
Junda WangCICS, University of Massachusetts, Amherst, MA, USA.
Sunjae KwonCICS, University of Massachusetts, Amherst, MA, USA.
Hong YuCICS, University of Massachusetts, Amherst, MA, USA.

Funding

Social and behavioral determinants of health and Alzheimer’s Disease: Cohort study of the US military veteran populationR01AG080670 · NIA · UNIVERSITY OF MASSACHUSETTS LOWELL · PI HONG YU · 2023 to 2026
$4.5M
Social and behavioral determinants of MOUD utilization and opioid overdoseR01DA056470 · NIDA · UNIVERSITY OF MASSACHUSETTS LOWELL · PI Wenjun Li, DAVID A SMELSON · 2023 to 2026
$2.9M
HSRD VA I01 HX000281HSRD VA I01 HX003711HSRD VA I01 HX003969NIA NIH HHS R01 AG080670NIDA NIH HHS R01 DA056470
6 · The paper itself

Abstract

This paper presents our team's participation in the MEDIQA-ClinicalNLP 2024 shared task B. We present a novel approach to diagnosing clinical dermatology cases by integrating large multimodal models, specifically leveraging the capabilities of GPT-4V under a retriever and a re-ranker framework. Our investigation reveals that GPT-4V, when used as a retrieval agent, can accurately retrieve the correct skin condition 85% of the time using dermatological images and brief patient histories. Additionally, we empirically show that Naive Chain-of-Thought (CoT) works well for retrieval while Medical Guidelines Grounded CoT is required for accurate dermatological diagnosis. Further, we introduce a Multi-Agent Conversation (MAC) framework and show it's superior performance and potential over the best CoT strategy. The experiments suggest that using naive CoT for retrieval and multi-agent conversation for critique-based diagnosis, GPT-4V can lead to an early and accurate diagnosis of dermatological conditions. The implications of this work extend to improving diagnostic workflows, supporting dermatological education, and enhancing patient care by providing a scalable, accessible, and accurate diagnostic tool.

Identifiers

PMID41664802
PMCPMC12883165

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.